Protocols, doses, and reactions reported below come from small published clinical trials and self-reported community sources
Personalized Care: Treatment plans are customized to align with your individual health goals
Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
The findings align with growing clinical evidence that GLP-1 therapy positively affects cardiometabolic risk factors, including blood pressure, blood sugar, and lipid profiles, even in complex patient populations
February 2021 version
The trial randomized over 1,600 participants across the U.S., Argentina, Australia, Brazil, China, Czechia, Germany, Greece, India, South Korea and Puerto Rico to receive various doses of orforglipron or placebo along with healthy diet and physical activity